21 CFR Part 600 · Biological Products: General

§ 600.22 § 600.22 [Reserved]

Subpart C - Establishment Inspection Official text on eCFR Amendment history

[Reserved] Subpart D—Reporting of Adverse Experiences SOURCE: 59 FR 54042, Oct. 27, 1994, unless otherwise noted.

Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.

FDA guidance that cites § 600.22

Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further Manufacture: Final Guidance 1 Dec 2014

Amendment history

Federal Register documents that created or amended this section.

59 FR 54042 27 Oct 1994